FindTrial
Sign In

To Evaluate the Response of Etipathogenesis Based Marma Therapy on Spastic Cerebral Palsy Patients and To Design a Project on Wellequipped Center of Neurological Disorders

To Evaluate the Response of Etipathogenesis Based Marma Therapy on Spastic Cerebral Palsy Patients and To Design a Project on Well-equipped Center of Neurological Disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075876
Enrollment
20
Registered
2024-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G00-G99- Diseases of the nervous system

Interventions

None listed

Sponsors

Banaras Hindu University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: cerebral palsy patient specialy spastic cerebral palsy patient

Exclusion criteria

Exclusion criteria: children suffering from any acute life-threatening illness any congenital malformation or genetic disorder

Design outcomes

Primary

MeasureTime frame
GMFCS Level Assessment Goniometer Assessment Language Milestone Investigation as per IPD protocolTimepoint: At registration 15th day and after 1 month of registration—

Secondary

MeasureTime frame
To improve quality of life & reduce spasticityTimepoint: At registration 15th day & 1 month after registration—

Countries

India

Contacts

Public ContactShree Devvrat ji

Institute of medical sciences, BHU

bms@bhu.ac.in9415286910

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026